MTAP DELETION

Clinical trials for MTAP DELETION explained in plain language.

Never miss a new study

Get alerted when new MTAP DELETION trials appear

Sign up with your email to follow new studies for MTAP DELETION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New drug targets hard-to-treat cancers with missing gene

Disease control Not yet recruiting

This early-stage study tests a new drug called HS-10587 in people with advanced solid tumors that have a missing MTAP gene. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 362 adults who have tried other treatments without suc…

Matched conditions: MTAP DELETION

Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 07:22 UTC

MTAP DELETION

Get alerted when new MTAP DELETION trials appear

New drug targets hard-to-treat cancers with missing gene